Potentially Malignant Oral Disorders: Risk Factors and p16 INK4a Expression
DOI:
https://doi.org/10.17533/udea.iatreia.243Keywords:
Oral Neoplasms, Oral Leukoplakia, Human Papillomavirus, P16ink4a GenesAbstract
The incidence of potentially malignant oral disorders (PMODs) of the oral cavity has risen in recent years, necessitating the identification of both modifiable and non-modifiable risk factors, as well as infection by high-risk human papillomavirus (HPV) genotypes. These have become the subject of numerous studies aimed at determining which patients are at increased risk of progressing to oral squamous cell carcinoma (OSCC). The aim of this review was to identify the major risk factors described for PMODs and to evaluate the research conducted on the role of p16 INK4a immunohistochemical staining in the progression of these lesions. A narrative review of the literature published in the last 50 years was conducted using the PUBMED, MEDLINE, and SCOPUS databases. Findings indicate that the incidence of disorders varies significantly by sex and age; the primary risk habits include chronic alcohol consumption and smoking. Finally, insufficient evidence was found to correlate high-risk HPV genotype infection and p16 INK4a immunohistochemical staining in determining which low-grade lesions will become malignant.
Downloads
References
(1) Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med [Internet]. 2008 Jan 1;37(1):1–10. https://doi.org/10.1111/j.1600-0714.2007.00579.x
(2) Mello FW, Miguel AFP, Dutra KL, Porporatti AL, Warnakulasuriya S, Guerra ENS, et al. Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis. J Oral Pathol Med [Internet]. 2018 Aug ;47(7):633–40. https://doi.org/10.11 11/jop.12726
(3) Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol [Internet]. 2003;39(8):770–80. https://doi.org/10.1016/S1368-8375(03)00102-7
(4) Amagasa T, Yamashiro M, Uzawa N. Oral premalignant lesions: from a clinical perspective. Int J Clin Oncol [Internet]. 2011;16(1):5–14. https://doi.org/10.1007/s10147-010-0157-3
(5) Foy JP, Bertolus C, Ortiz-Cuaran S, Albaret MA, Williams WN, Lang W, et al. Immunological and classical subtypes of oral premalignant lesions. Oncoimmunology [Internet]. 2018 Sep 21;7(12):e1496880–e1496880. https://doi.org/10.1080/2162402X.2018.1496880
(6) Kramer IR, Lucas RB, Pindborg JJ, Sobin LH. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol [Internet]. 1978 Oct;46(4):518–39. https://doi.org/10.1016/0030-4220%2878%2990383-3
(7) Wright JM. A review and update of oral precancerous lesions. Tex Dent J [Internet]. 1998 Jun; 115(6):15–9. https://doi.org/10.12998%2Fwjcc.v2.i12.866
(8) Califano J, Westra WH, Meininger G, Corio R, Koch WM, Sidransky D. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res [Internet]. 2000 Feb;6(2):347–52. Available from: https://aacrjournals.org/clincancerres/article/6/2/347/287957/Genetic-Progression-and-Clonal-Relationship-of
(9) Tabor MP, Brakenhoff RH, van Houten VM, Kummer JA, Snel MH, Snijders PJ, et al. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res [Internet]. 2001 Jun;7(6):1523–32. Available from: https://aacrjournals.org/clincancerres/article/7/6/1523/288845/Persistence-of-Genetically-Altered-Fields-in-Head
(10) Partridge M, Pateromichelakis S, Phillips E, Emilion G, Langdon J. Profiling clonality and progression in multiple premalignant and malignant oral lesions identifies a subgroup of cases with a distinct presentation of squamous cell carcinoma. Clin Cancer Res [Internet]. 2001 Jul;7(7):1860–6. Available from: https://aacrjournals.org/clincancerres/article/7/7/1860/288743/Profiling-Clonality-and-Progression-in-Multiple
(11) Warnakulasuriya S. Oral potentially malignant disorders: A comprehensive review on clinical aspects and management. Oral Oncol [Internet]. 2020;102:104550. https://doi.org/10.1016/j.oraloncology.2019.104550
(12) Burzynski NJ, Firriolo FJ, Butters JM, Sorrell CL. Evaluation of oral cancer screening. J Cancer Educ [Internet]. 1997;12(2):95–9. Available from: https://pubmed.ncbi.nlm.nih.gov/9229272/
(13) Bouquot JE. Common oral lesions found during a mass screening examination. The Journal of the American Dental Association [Internet]. 1986 Jan;112(1):50–7. https://doi.org/10.14219/jada.archive.1986.0007
(14) Thomson PJ. Field change and oral cancer: new evidence for widespread carcinogenesis? Int J Oral Maxillofac Surg [Internet]. 2002 Jun;31(3):262–6. https://doi.org/10.1054/ijom.2002.0220
(15) Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, Bagan JV, González-Moles MÁ, Kerr AR, et al. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis [Internet]. 2021 Nov 1;27(8):1862–80. https://doi.org/10.1111/odi.13704
(16) Haya-Fernández M, Bagán JV, Murillo-Cortés J, Poveda-Roda R, Calabuig C. The prevalence of oral leukoplakia in 138 patients with oral squamous cell carcinoma. Oral Dis [Internet]. 2004 Nov 1;10(6):346–8. https://doi.org/10.1111/j.1601-0825.2004.01031.x
(17) Hanahan D, Weinberg RA. Hallmarks of Cancer: The Next Generation. Cell [Internet]. 2011 Mar 4;144(5):646–74. https://doi.org/10.1016/j.cell.2011.02.013
(18) Global Cancer Observatory. World Health Organization. International Agency for Research on Cancer [Internet]. 2020. Disponible en: https://gco.iarc.fr/
(19) Petersen PE. Oral cancer prevention and control – The approach of the World Health Organization. Oral Oncol [Internet]. 2009;45(4):454–60. Available from: https://www.sciencedirect.com/science/article/pii/S1368837508001760
(20) El-Naggar AK. WHO Classification of Head and Neck Tumours. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. 4th ed. 2017. p. 112–3.
(21) Yardimci G, Kutlubay Z, Engin B, Tuzun Y. Precancerous lesions of oral mucosa. World J Clin Cases [Internet]. 2014 Dec 16;2(12):866–72. https://doi.org/10.12998/wjcc.v2.i12.866
(22) van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol [Internet]. 2009;45(4):317–23. https://doi.org/10.1016/j.oraloncology.2008.05.016
(23) Wu W, Wang Z, Zhou Z. Role of the human papillomavirus in malignant transformation of oral leukoplakia distinct from oropharyngeal squamous cell carcinoma: A study of 76 patients with internal-control specimens. Oral Surg Oral Med Oral Pathol Oral Radiol [Internet]. 2019 Sep;128(3):273–9. https://doi.org/10.1016/j.oooo.2019.01.004
(24) Warnakulasuriya S, Ariyawardana A. Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med [Internet]. 2016 Mar 1;45(3):155–66. https://doi.org/10.1111/jop.12339
(25) Farah CS, Woo SB, Zain RB, Sklavounou A, McCullough MJ, Lingen M. Oral cancer and oral potentially malignant disorders. Int J Dent [Internet]. 2014;2014:853479. https://doi.org/10.1155%2F2014%2F853479
(26) Kharma MY, Tarakji B. Current evidence in diagnosis and treatment of proliferative verrucous leukoplakia. Ann Saudi Med [Internet]. 2012 Jul-Aug;32(4):412–414. https://doi.org/10.5144%2F0256-4947.2012.412
(27) Upadhyaya JD, Fitzpatrick SG, Islam MN, Bhattacharyya I, Cohen DM. A Retrospective 20-Year Analysis of Proliferative Verrucous Leukoplakia and Its Progression to Malignancy and Association with High-risk Human Papillomavirus. Head Neck Pathol [Internet]. 2018 Dec 9;12(4):500–10. https://doi.org/10.1007/s12105-018-0893-7
(28) Bagan J V., Jimenez Y, Murillo J, Gavaldá C, Poveda R, Scully C, et al. Lack of Association Between Proliferative Verrucous Leukoplakia and Human Papillomavirus Infection. J Oral Maxillofac Surg [Internet]. 2007 Jan;65(1):46–9. https://doi.org/10.1016/j.joms.2005.12.066
(29) Pierangeli A, Cannella F, Scagnolari C, Gentile M, Sciandra I, Antonelli G, et al. Frequent detection of high human papillomavirus DNA loads in oral potentially malignant disorders. Clin Microbiol Infect [Internet]. 2016 Jan;22(1):95.e9-95.e15. https://doi.org/10.1016/j.cmi.2015.09.011
(30) Stanley MA, Winder DM, Sterling JC, Goon PKC. HPV infection, anal intra-epithelial neoplasia (AIN) and anal cancer: current issues. BMC Cancer [Internet]. 2012;12(1):398. https://doi.org/10.1186/1471-2407-12-398
(31) Zendeli-Bedjeti L, Popovska M, Atanasovska-Stojanovska A, Duvlis S. Human Papillomavirus as a Potential Risk Factor for Oral Premalignant Lesions. Acta Clin Croat [Internet]. 2017 Sep;56(3):369-374. https://doi.org/10.20471/acc.2017.56.03.02
(32) Chuerduangphui J, Pientong C, Chaiyarit P, Patarapadungkit N, Chotiyano A, Kongyingyoes B, et al. Effect of human papillomavirus 16 oncoproteins on oncostatin M upregulation in oral squamous cell carcinoma. Med Oncol [Internet]. 2016 Aug;33(8):83. https://doi.org/10.1007/s12032-016-0800-6
(33) Ostwald C, Rutsatz K, Schweder J, Schmidt W, Gundlach K, Barten M. Human papillomavirus 6/11, 16 and 18 in oral carcinomas and benign oral lesions. Med Microbiol Immunol [Internet]. 2003 Aug;192(3):145–8. https://doi.org/10.1007/s00430-002-0161-y
(34) Golusinski P. Risk Factors for Oral Infection with Human Papillomavirus. Recent Results Cancer Res [Internet]. 2017;206:73-85. https://doi.org/10.1007/978-3-319-43580-0_5
(35) Einhorn J, Wersall J. Incidence of oral carcinoma in patients with leukoplakia of the oral mucosa. Cancer [Internet]. 1967 Dec;20(12):2189–93. https://doi.org/10.1002/1097-0142(196712)20:12%3C2189::aid-cncr2820201218%3E3.0.co;2-m
(36) Bánóczy J, Sugár L. Longitudinal studies in oral leukoplakias. J Oral Pathol [Internet]. 1972;1(6):265–72. https://doi.org/10.1111/j.1600-0714.1972.tb01665.x
(37) Silverman S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer [Internet]. 1984 Feb 1;53(3):563–8. https://doi.org/10.1002/1097-0142(19840201)53:3%3C563::aid-cncr2820530332%3E3.0.co;2-f
(38) Castagnola P, Zoppoli G, Gandolfo S, Monticone M, Malacarne D, Cirmena G, et al. Genomic DNA Copy Number Aberrations, Histological Diagnosis, Oral Subsite and Aneuploidy in OPMDs/OSCCs. PLoS One [Internet]. 2015;10(11):e0142294. https://doi.org/10.1371%2Fjournal.pone.0142294
(39) Wood HM, Daly C, Chalkley R, Senguven B, Ross L, Egan P, et al. The genomic road to invasion-examining the similarities and differences in the genomes of associated oral pre-cancer and cancer samples. Genome Med [Internet]. 2017;9(1):53. https://doi.org/10.1186%2Fs13073-017-0442-0
(40) Garnis C, Chari R, Buys TP, Zhang L, Ng RT, Rosin MP, et al. Genomic imbalances in precancerous tissues signal oral cancer risk. Mol Cancer [Internet]. 2009;8(1):50. https://doi.org/10.1186/1476-4598-8-50
(41) Ogmundsdóttir HM, Björnsson J, Holbrook WP. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients. J Oral Pathol Med [Internet]. 2009 Aug;38(7):565–71. https://doi.org/10.1111/j.1600-0714.2009.00766.x
(42) McCord C, Xu J, Xu W, Qiu X, McComb RJ, Perez-Ordonez B, et al. Association of high-risk human papillomavirus infection with oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol [Internet]. 2013 Apr;115(4):541–9. https://doi.org/10.1016/j.oooo.2013.01.020
(43) Bradley KT, Budnick SD, Logani S. Immunohistochemical detection of p16INK4a in dysplastic lesions of the oral cavity. Modern Pathology [Internet]. 2006 Oct 23;19(10):1310–6. https://doi.org/10.1038/modpathol.3800649
(44) Sundberg J, Korytowska M, Burgos PM, Blomgren J, Blomstrand L, DE Lara S, et al. Combined Testing of p16 Tumour-suppressor Protein and Human Papillomavirus in Patients With Oral Leukoplakia and Oral Squamous Cell Carcinoma. Anticancer Res [Internet]. 2019 Mar; 39(3):1293–300. https://doi.org/10.21873/anticanres.13241
(45) Wu W, Wang Z, Zhou Z. Role of the human papillomavirus in malignant transformation of oral leukoplakia distinct from oropharyngeal squamous cell carcinoma: A study of 76 patients with internal-control specimens. Oral Surg Oral Med Oral Pathol Oral Radiol [Internet]. 2019 Sep 1;128(3):273–9. https://doi.org/10.1016/j.oooo.2019.01.004
(46) Gomez-Armayones S, Chimenos-Küstner E, Marí A, Tous S, Penin R, Clavero O, et al. Human papillomavirus in premalignant oral lesions: No evidence of association in a Spanish cohort. PLoS One [Internet]. 2019 Jan 16;14(1):e0210070. https://doi.org/10.1371/journal.pone.0210070
(47) Lajous M, Mueller N, Cruz-Valdéz A, Aguilar LV, Franceschi S, Hernández-Avila M, et al. Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev [Internet]. 2005 Jul;14(7):1710–6. https://doi.org/10.1158/1055-9965.epi-04-0926
(48) Alvarez-Gómez GJ, Alvarez-Martínez E, Jiménez-Gómez R, Mosquera-Silva Y, Gaviria-Núñez AM, Garcés-Agudelo A, et al. Reverse smokers’s and changes in oral mucosa. Department of Sucre, Colombia. Med Oral Patol Oral Cir Bucal [Internet]. 2008 Jan 1;13(1):E1-8. Available from: https://pubmed.ncbi.nlm.nih.gov/18167472/
(49) Xi LF, Koutsky LA, Castle PE, Edelstein ZR, Meyers C, Ho J, et al. Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load. Cancer Epidemiol Biomarkers Prev [Internet]. 2009 Dec;18(12):3490–6. https://doi.org/10.1158%2F1055-9965.EPI-09-0763
(50) Alam S, Conway MJ, Chen HS, Meyers C. The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis. J Virol [Internet]. 2008 Jan; 82(2): 1053–8. DOI: https://doi.org/10.1128%2FJVI.01813-07
(51) Zambrano-Ríos D, Fernández F, Matta-Miramar A, Arbelaez A, Herrera-Castañeda E, Castillo A. Detección del virus del papiloma humano en mucosa oral de mujeres de Cali, Colombia. Infectio [Internet]. 2019 Mar 19;23(3):266. https://doi.org/10.22354/in.v23i3.791
(52) Jayaprakash V, Reid M, Hatton E, Merzianu M, Rigual N, Marshall J, et al. Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010. Oral Oncol [Internet]. 2011 Nov;47(11):1048–54. https://doi.org/10.1016%2Fj.oraloncology.2011.07.009
(53) Akhondnezhad M, Haghshenas MR, Ghasemi M, Mousavi T. The prevalence and genotyping of human papillomavirus in patients with oral tumors in health centers and clinics of Mazandaran in Iran. Virusdisease [Internet]. 2018 Sep;29(3):297–302. https://doi.org/10.1007/s13337-018-0472-2
(54) Salehinejad J, Sharifi N, Amirchaghmaghi M, Ghazi N, Shakeri MT, Ghazi A. Immunohistochemical expression of p16 protein in oral squamous cell carcinoma and lichen planus. Ann Diagn Pathol [Internet]. 2014 Aug;18(4):210–3. https://doi.org/10.1016/j.anndiagpath.2014.03.009
(55) Yang LQ, Xiao X, Li CX, Wu WY, Shen XM, Zhou ZT, et al. Human papillomavirus genotypes and p16 expression in oral leukoplakia and squamous cell carcinoma. Int J Clin Exp Pathol [Internet]. 2019;12(3):1022–8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945145/
(56) Romagosa C, Simonetti S, López-Vicente L, Mazo A, Lleonart ME, Castellvi J, et al. p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors. Oncogene [Internet]. 2011 May 5;30(18):2087–97. https://doi.org/10.1038/onc.2010.614
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Iatreia
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Papers published in the journal are available for use under the Creative Commons license, specifically Attribution-NonCommercial-ShareAlike 4.0 International.
The papers must be unpublished and sent exclusively to the Journal Iatreia; the author uploading the contribution is required to submit two fully completed formats: article submission and authorship responsibility.
